 Correlative studies investigating PD-L-1 expression in tumor tissue will be assessed with clinical outcome. Peripheral blood will also be drawn to perform immunologic markers and hepatitis B or C viral titers. This is to determine if viral titers change with treatment. These studies are included for all patients who consent to the correlative studies See Appendix F. There is an additional consent for the correlative studies. 